LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Image: The platform leverages CRISPR technology to enable tuberculosis detection directly from blood samples (Photo courtesy of IntelliGenome)

Blood-Based CRISPR Test for Tuberculosis Gains Regulatory Approval in Colombia

IntelliGenome receives INVIMA approval for CRISPR-TB blood test and appoints Velez Lab as Colombia distributor. More...
06 Jul 2026
Image: The joint workflow is positioned to provide complete, practical, and easy-to-use DNA and RNA quantification across research settings

Partnership Integrates Automated DNA Extraction with Single-Molecule Digital PCR

A new workflow unites automated nucleic acid extraction and single-molecule PCR to improve rare variant detection in cfDNA. More...
01 Jul 2026
Image: Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group, expanding the company’s pathology portfolio across clinical and research settings

Agilent Strengthens Pathology Capabilities Through Biocare Acquisition

Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group, expanding its clinical and research pathology portfolio. More...
29 Jun 2026
Image: The planned Bio-Techne acquisition would strengthen Merck KGaA, Darmstadt, Germany, in multi-omics, spatial biology, cell and gene therapy, precision diagnostics, and research tools.

Merck KGaA to Acquire Bio-Techne, Expanding Life Science Portfolio

Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in fast-growing life sciences markets. More...
29 Jun 2026
Image: a new initiative aims to bring greater precision to this class of therapeutics (Photo courtesy of One Biosciences)

Project Aims to Develop First Single-Cell Assay for ADC Therapies

One Biosciences receives Paris Saclay Cancer Cluster BOOST funding to advance a single-cell assay approach for antibody-drug conjugate therapies. More...
26 Jun 2026
Image: The proposed immunoassay uses ALZpath’s pTau217 antibody to detect Alzheimer’s disease biology in blood, supporting the growing role of blood-based biomarkers in clinical care (Photo courtesy of Shutterstock)

Agreement Supports pTau217-Based Alzheimer’s Blood Test Development

ALZpath is licensing its proprietary pTau217 antibody to Abbott for development of an Alzheimer’s disease IVD test. More...
26 Jun 2026
Image: Volition’s Nu.Q NETs test detects markers associated with neutrophil extracellular traps, which are released during NETosis and linked to sepsis and other acute and chronic disorders (Image credit: iStock)

Collaboration Aims to Broaden Access to NETosis-Linked Disease Testing

VolitionRx announced a collaboration with Sysmex Corporation to optimize Volition’s Nu.Q NETs H3.1 assay on the Sysmex platform.  More...
25 Jun 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
Gold Member
Serum Indices Control
Acusera Serum Indices Control


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.